Predictive Factors for Progression in Patients with Clinical Stage T1a Prostate Cancer in the PSA Era

European Urology

Volumn 53, Issue 2, 2008, Pages 355-362

  Descazeaud, Aurelien ^a   Peyromaure, Michael ^a   Salin, Ambroise ^a   Amsellem Ouazana, Delphine ^a   Flam, Thierry ^a   Viellefond, Annick ^a   Debré, Bernard ^a   Zerbib, Marc ^a  

^a Institut Cochin   (France)

Author keywords

Benign prostatic hyperplasia; Predictive factors; Prostate cancer; T1a

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSURETHRAL RESECTION;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS; ROC CURVE;

EID: 37349125310     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.06.020     Document Type: Article

References (23)

1. Fleming I.D., Coper J.S., Henson D.E., et al. American Joint Committee on Cancer staging manual. ed. 5 (1997), Lippincott Raven, Philadelphia
2. Fowler Jr. J.E., Pandey P., Bigler S.A., Yee D.T., and Kolski J.M. Trends in diagnosis of stage T1a-b prostate cancer. J Urol 158 (1997) 1849-1852
3. Zigeuner R.E., Lipsky K., Riedler I., et al. Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 62 (2003) 451-455
4. Zhang G., Wasserman N.F., Sidi A.A., Reinberg Y., and Reddy P.K. Long-term followup results after expectant management of stage A1 prostatic cancer. J Urol 146 (1991) 99-102 discussion, 102-3
5. Cheng L., Bergstralh E.J., Scherer B.G., et al. Predictors of cancer progression in T1a prostate adenocarcinoma. Cancer 85 (1999) 1300-1304
6. Epstein J.I., Paull G., Eggleston J.C., and Walsh P.C. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. J Urol 136 (1986) 837-839
7. Larsen M.P., Carter H.B., and Epstein J.I. Can stage A1 tumor extent be predicted by transurethral resection tumor volume, per cent or grade? A study of 64 stage A1 radical prostatectomies with comparison to prostates removed for stages A2 and B disease. J Urol 146 (1991) 1059-1063
8. Blute M.L., Zincke H., and Farrow G.M. Long-term followup of young patients with stage A adenocarcinoma of the prostate. J Urol 136 (1986) 840-843
9. Cantrell B.B., DeKlerk D.P., Eggleston J.C., Boitnott J.K., and Walsh P.C. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent versus grade. J Urol 125 (1981) 516-520
10. Epstein J.I. Can insignificant prostate cancer be predicted preoperatively in men with stage T1 disease?. Semin Urol Oncol 14 (1996) 165-173
11. Masue N., Deguchi T., Nakano M., Ehara H., Uno H., and Takahashi Y. Retrospective study of 101 cases with incidental prostate cancer stages T1a and T1b. Int J Urol 12 (2005) 1045-1049
12. Schmid H.P., Adolfsson J., and Aus G. Active monitoring (deferred treatment or watchful waiting) in the treatment of prostate cancer. A review. Eur Urol 40 (2001) 488-494
13. Thompson I.M., and Zeidman E.J. Extended follow-up of stage A1 carcinoma of prostate. Urology 33 (1989) 455-458
14. van Andel G., Vleeming R., Kurth K., and de Reijke T.M. Incidental carcinoma of the prostate. Semin Surg Oncol 11 (1995) 36-45
15. Zincke H., Blute M.L., Fallen M.J., and Farrow G.M. Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome. J Urol 146 (1991) 1053-1058
16. Matzkin H., Patel J.P., Altwein J.E., and Soloway M.S. Stage T1A carcinoma of prostate. Urology 43 (1994) 11-21
17. Puppo P., Introini C., Calvi P., and Naselli A. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 49 (2006) 873-878
18. Bratt O. The difficult case in prostate cancer diagnosis-when is a "diagnostic TURP" indicated?. Eur Urol 49 (2006) 769-771
19. Humphrey P.A., and Vollmer R.T. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol 21 (1990) 799-804
20. Daver A., Soret J.Y., Coblentz Y., Allain Y.M., Cellier P., and Chauveau P. The usefulness of prostate-specific antigen and prostatic acid phosphatase in clinical practice. Am J Clin Oncol 11 Suppl 2 (1988) S53-S60
21. Chang C.P., Chang Y.H., Chiang H., Chen M.T., and Chang L.S. Incidental adenocarcinoma of the prostate: a retrospective analysis. Eur Urol 20 (1991) 282-286
22. Voges G.E., McNeal J.E., Redwine E.A., Freiha F.S., and Stamey T.A. The predictive significance of substaging stage A prostate cancer (A1 versus A2) for volume and grade of total cancer in the prostate. J Urol 147 (1992) 858-863
23. Chen W.M., Yang C.R., Ou Y.C., et al. Clinical outcome of patients with stage T1a prostate cancer. J Chin Med Assoc 66 (2003) 236-240